The end of evidence-based medicine?

Inflammopharmacology

Volumn 20, Issue 4, 2012, Pages 187-193

  Clark, David A ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Evidence based medicine; Observational studies; Results based medicine

Indexed keywords

IMMUNOGLOBULIN G; NONSTEROID ANTIINFLAMMATORY AGENT;

CLINICAL STUDY; DRUG APPROVAL; DRUG RESEARCH; EVIDENCE BASED MEDICINE; HUMAN; OBSERVATIONAL STUDY; OUTCOMES RESEARCH; PATIENT PREFERENCE; PEER REVIEW; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; RECURRENT ABORTION; RESEARCH SUBJECT; REVIEW; SAMPLING; SYSTEMATIC ERROR; TREATMENT OUTCOME;

BIAS (EPIDEMIOLOGY); EVIDENCE-BASED MEDICINE; HUMANS; META-ANALYSIS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84864921411     PISSN: 09254692     EISSN: 15685608     Source Type: Journal    
DOI: 10.1007/s10787-012-0119-7     Document Type: Review

References (41)

1. Armitage J (2011) Randomized trials remain essential and are not overrated. J Roy Coll Phys Edin 41:126-131
2. Ata B, Tan SL, Shehata F, Holzer H, Buckett W (2011) A systematic review of intravenous immunoglobulin for the treatment of unexplained recurrent miscarriage. Fertil Steril. doi:10.1016/ j.fertnstert.2010.12.021
3. Benson K, Hartz AJ (2000) A comparison of observational studies and randomized controlled trials. New Engl J Med 342:1878-1886 (Pubitemid 30419053)
4. Bohluis J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfield J, Zeahlen M, Clarke M, Weingart O, Kluge S, Piper M, Rades D, Steensma DP, Djelbegovic B, Fey MF, Ray-Coquard I, Machtay M, Moebus V, Thomas G, Untch M, Schumacher M, Egger M, Engert A (2009) Recombinant human erythropoesisstimulating agents and mortality in patients with cancer: a metaanalysis of randomized trials. Lancet 373:1532-1542
5. Buchanan WW, Kean WF (2001a) Rheumatoid arthritis: through long distance spectacles. Inflammopharmacol 9:3-22 (Pubitemid 32631437)
6. Buchanan WW, Kean WF (2001b) Rheumatoid arthritis: beyond the lymphocyte. J Rheumatol 28:691-693
7. Buchanan WW, Kean WF (2001c) Clinical judgement and evidence based medicine. Jt Bone Spine 68:370-372 (Pubitemid 32988521)
8. Buchanan WW, Kean WF (2001d) Evidence-based medicine: the median is not the message. J Rheumatol 28:2371-2372 (Pubitemid 33031961)
9. Clark DA (2007) Is paternal leukocyte immunotherapy indicated ? In: Carp HJA (ed) Controversies in Obstetrics and Gynaecology, Informa Healthcare, Oxon (UK) pp 179-184
10. Clark DA (2008) Immunological factors in pregnancy wastage: fact or fiction. Am J Reprod Immunol 59:277-300 (Pubitemid 351404249)
11. Clark DA (2009) Should anti-TNF-a therapy be offered to patients with infertility and recurrent spontaneous abortion ? Am J Reprod Immunol 61:107-112
12. Clark DA (2011a) Anti-TNFα therapy in immune mediated infertility: state of the art. J Reprod Immunol 85:15-24
13. Clark DA (2011b) The power of observation. Am J Reprod Immunol 66:71-75 (corrigendum 61:162)
14. Clark DA (2011c) Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: methodological problems. Human Reprod 26:2586-2587
15. Clark DA, Gunby J, Daya S (1997) The use of allogeneic leukocytes or IV IgG for the treatment of patients with recurrent spontaneous abortions. Transfus Med Rev 11:85-94 (Pubitemid 27202243)
16. Clark DA, Coulam CB, Daya S, Chaouat G (2001) Unexplained sporadic and recurrent miscarriage in the new millennium: a critical analysis of immune mechanisms and treatment. Human Reprod Update 7:501-511 (Pubitemid 32827551)
17. Clarke R, Halsey J, Lewington S, Lonn E, Armitage J, Manson JE, Bonaa KH, Spence JD, Nygard O, Jamison R, Gaziano JM, Guarino P, Bennett D, Mir F, Peto R, Collins R (2010) Effect of lowering homocysteine levels with B vitamins on cardiovascular disease cancer, and cause-specific mortality. Arch Int Med
18. Guarino P, Bennett D, Mir F, Peto R, Collins R (2010) Effect of lowering homocysteine levels with B vitamins on cardiovascular disease cancer, and cause-specific mortality. Arch Int Med 170:1622-1631
19. Codman EA (1916) A Study in Hospital Efficiency. Special Edition (re)printed 1992 by The Classics of Medicine Library, Gryphton, New York, NY, USA
20. Concatto J (2004) Observational versus experimental studies: what's the evidence for a hierarchy ? NeuroRx 1:341-347
21. Concatto J, Shaw H, Horowitz RE (2000) Randomized controlled trials, observational studies, and hierarchy of research designs. New Engl J Med 342:1877-1892
22. Dans AL, Teo K, Gao P, Chen J-H, Jae-Hyung K, Yusoff K, Chaithirapan S, Zhu J, Lisheng L, Yusuf S, for the ONTARGETINVESTIGATORS (2010) In a subgroup of high-risk Asians, telmisartin was noninferior to ramipril and better tolerated in the prevention of cardiovascular events. Plos ONE [Electronic Resource] 5(12):e13694
23. Egger M, Smith GD, Schneider M, Minder C (1997) Bias in metaanalysis detected by a simple graphical test. BMJ 315:629-634 (Pubitemid 27387172)
24. Elwood PM (1988) Special Report, Shattuck Lecture - Outcomes Management, A technology of patient experience. New Engl J Med 310:1549-1556
25. Guyatt G, Sackett D, Adachi J, Roberts R, Chong J, Rosenbloom D, Keller J (1988) A clinician's guide for conducting randomized trials in individual patients. Can Med Assoc J 139:497-503
26. Ioannidis JPA, Haidich AB, Pappa M, Pantazis N, Kokori SI, Tektonidou MG, Contopoulos-Ioannidis DG, Lau J (2001) Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 286:821-830 (Pubitemid 33015576)
27. Jeng GT, Scott JR, Burmeister LF (1995) A comparison of metaanalytic results using literature vs individual patient data. Paternal leukocyte immunotherapy for recurrent miscarriage. JAMA 274:830-836
28. Liebovici L (1991) Effects of remote, retroactive intercessory prayer on outcomes in patients with bloodstream infections: randomized controlled trial. BMJ 323:1450-1451
29. Maclure M (1996a) Dr. Tom Chalmers, 1917-1995: the trials of a randomizer. Can Med Assoc J 155:757-762
30. Maclure M (1996b) Dr. Tom Chalmers, 1917-1995: the trials of a randomizer, continued. Can Med Assoc J 155:986-988
31. Ober C, Karrison T, Odem RR, Barnes RB, Brach DW, Stephenson MD, Baron B, Walker MA, Scott JR, Schreiber JR (1999) Mononuclear-cell immunization is prevention of recurrent miscarriages: a randomized trial. Lancet 354:365-369 (Pubitemid 29355752)
32. Ottenbacher K (1992) Impact of random assignment on study outcome: an empirical examination. Controlled Clin Trials 13:50-61
33. Oxman AD, Clarke MJ, Stewart LA (1995) From science to practice. Meta-analysis using individual patient data are needed. JAMA 274:845-846
34. Porter TF, LaCoursiere Y, Scott JR (2006) Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev (2) CD000112
35. RMITG (Recurrent Miscarriage Immunotherapy Trialists Group) (1994) Worldwide collaborative observational study and metaanalysis on allogeneic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol 32:55-72
36. Sackett DL, Hoey J (2000) Why clinical trials fail but needn't: a new series is launched. Can Med Assoc J 162:1311-1314
37. Sackett D, Rosenberg WMC, Gray JA, Haynes RB, Richardson WS (1997) Evidence-based medicine: what it is and what it isn't. BMJ 312:71-72
38. Shakespeare W (1623) Macbeth, Act V, Scene V. In: Alexander P (ed) The Complete Works of William Shakespeare, 1961 edition, Collins Clear-Type Press, London
39. Tsimberidou AM, Braiteh F, Stewart DJ, Kurzrock R (2009) Ultimate fate of oncology drugs approved by the US food and drug administration with a randomized trial. J Clin Oncol 27:6243-6250
40. Vist GE, Bryant D, Somerville L, Birmingham T Oxman AD (2008) Outcome of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate. Cochrane Database Syst Rev (3) MR000009
41. Winger EE, Reed J (2011) Low circulating CD4? CD25? FOXP3? T regulatory cell levels predict miscarriage risk in newly pregnant women with a history of failure. Am J Reprod Immunol 66:320-328